Chantal Frigon

Dr. Chantal Frigon

McGill University Health Center
+1

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2004 in Journal of Perinatology
Verified
Journal Article
Closed access
MNMichael D Neufeld
Michael D Neufeld
CFChantal Frigon
Chantal Frigon
AGAlan S Graham
Alan S Graham
BMBeth A Mueller
Beth A Mueller

9 August 2006 in Pediatric Anesthesia
Verified
Journal Article
Closed access
PDF file
CFChantal Frigon
Chantal Frigon
RMRyan Mai
Ryan Mai
TVTeresa Valois‐Gomez
Teresa Valois‐Gomez
JDJoëlle Desparmet
Joëlle Desparmet

1 October 2004 in Radiology
Verified
Journal Article
Closed access
CFChantal Frigon
Chantal Frigon
DSDennis W. W. Shaw
Dennis W. W. Shaw
SHSusan R. Heckbert
Susan R. Heckbert
EWEdward Weinberger
Edward Weinberger
DJDavid S. Jardine
David S. Jardine
To prospectively test the hypothesis that high levels of the fraction of inspired oxygen (Fio(2)) during general anesthesia cause subarachnoid cerebrospinal fluid (CSF) hyperintensity during fluid-attenuated inversion-recovery (FLAIR) magnetic resonance (MR) imaging. At brain MR imaging during general anesthesia with propofol, two FLAIR sequences were performed in 20 children with American Society of Anesthesiologists physical status classification system grades of 3 or lower. The first FLAIR sequence was performed with the child breathing 100% oxygen; the second was performed with the child breathing 30% oxygen. CSF signal intensity was quantified on a three-point ordinal scale (0 = hypointense to brain parenchyma, 1 = isointense to brain parenchyma, 2 = hyperintense to brain parenchyma) by a pediatric neuroradiologist who was blinded to the Fio(2) level. The Wilcoxon signed rank test was used to determine if CSF hyperintensity was correlated with Fio(2). CSF hyperintensity was present in all 20 children (age range, 1.9-16.7 years; 12 children were boys) when the Fio(2) was 100%. The hyperintensity partially or completely disappeared in the basilar cisterns (P <.001) and cerebral sulcal subarachnoid space (P <.001) after Fio(2) was reduced from 100% to 30%. These findings are consistent with the hypothesis that increased arterial oxygen tension and consequently increased CSF Po(2) resulting from administration of high Fio(2) during general anesthesia are responsible for the increased CSF signal intensity noted on brain FLAIR MR images.

1 September 2002 in American Journal of Roentgenology
Verified
Journal Article
Closed access
CFChantal Frigon
Chantal Frigon
DJDavid S. Jardine
David S. Jardine
EWEd Weinberger
Ed Weinberger
SHSusan R. Heckbert
Susan R. Heckbert
DSDennis W. W. Shaw
Dennis W. W. Shaw
OBJECTIVE. Cerebrospinal fluid (CSF) hyperintensity has been described on fluid-attenuated inversion recovery (FLAIR) imaging in anesthetized patients who underwent MR imaging without apparent subarachnoid abnormality. The purpose of our study was to delineate likely causes for this hyperintensity. Specifically, we sought to determine whether a high inspired oxygen fraction given as part of the anesthetic was responsible for the CSF hyperintensity seen on FLAIR imaging.MATERIALS AND METHODS. A retrospective study was conducted using anesthetic records and brain MR images of 70 children and young adults who had a FLAIR sequence while undergoing general anesthesia. Information about inspired oxygen fraction, oxygen saturation, and type of anesthetic agents preceding the FLAIR sequence was obtained from the anesthetic record. A pediatric neuroradiologist who was unaware of the inspired oxygen fraction and anesthetic agent ascertained the presence of CSF hyperintensity in the basilar cisterns and cerebral sul...

1 January 2000 in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
Verified
Journal Article
Closed access
PDF file
RMRené Martin
René Martin
CFChantal Frigon
Chantal Frigon
ACAngelo Chrétien
Angelo Chrétien
JTJean-Pierre Tétrault
Jean-Pierre Tétrault

1 January 2006 in Pain Research and Management
Verified
Journal Article
Open access
PDF file
CFChantal Frigon
Chantal Frigon
JDJoëlle Desparmet
Joëlle Desparmet
The case of a seven‐year‐old boy with chronic pruritus secondary to a giant congenital melanocytic nevus is presented. The pruritus did not respond to conventional antipruritic drug treatment, but responded to ondansetron, a selective antagonist of 5‐hydroxytryptamine type 3 receptors.